Alkem to market Tiger Balm range of products in India

Image
Press Trust of India New Delhi
Last Updated : Feb 07 2017 | 3:57 PM IST
Drug firm Alkem Laboratories has inked a pact with Singapore's Haw Par Healthcare to market and distribute Tiger Balm range of products in India.
"The Mumbai-based company has entered into an alliance with Haw Par India, a wholly-owned subsidiary of Singapore's Haw Par Healthcare, to exclusively market and distribute Tiger Balm range of products in the country," Alkem Labs said in a regulatory filing.
Tiger Balm is used for headaches, upper respiratory congestions, arthritic pains and muscular sprains.
"Combined with Alkem's strong sales and distribution infrastructure and robust executional capabilities in India, we believe it is a befitting alliance which cannot only grow Tiger Balm's franchise in India but can also add significant thrust to Alkem's OTC business," Alkem CEO Prabhat Agrawal said.
As per Euromonitor 2015, the size of OTC analgesic market in India is about Rs 20 billion and has grown at a CAGR of 9.9 per cent through 2010 to 2015.
Tiger balm features amongst the top 10 brands in the topical OTC analgesic market in India.
Alkem shares were trading 0.45 per cent down at Rs 1,805.65 on the BSE.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 07 2017 | 3:57 PM IST

Next Story